title: Randomised trial of simulect versus placebo for control of acute rejection in renal allograft recipients.
authors.affiliation: Department of Urology, Professor and Director, Hospital of PLA, Beijing, China.
authors.forename: S
authors.initials: S
authors.lastname: Bingyi
authors.forename: Q
authors.initials: Q
authors.lastname: Yeyong
authors.forename: C
authors.initials: C
authors.lastname: Ming
authors.forename: M
authors.initials: M
authors.lastname: Chunbai
authors.forename: Z
authors.initials: Z
authors.lastname: Wenqiang
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011184:Postoperative Period; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D010919:Placebos; D011993:Recombinant Fusion Proteins